πŸ•΅οΈ Enovis Corp ($ENOV)

SEC insider & ownership activity, last 12 months Β· CIK 1420800 Β· every row links its SEC filing

Over the last 12 months insiders sold $45K against $977K of open-market buying. Daniel A. Pryor bought $289K in discretionary trades (Aug–Dec). No red-flag 8-Ks in the window.

Aug 2025: net +$464K Sep 2025: net +$200K Oct 2025: net +$0 Nov 2025: net +$75K Dec 2025: net -$45K Jan 2026: net +$0 Mar 2026: net +$120K Mar 2026: net +$120K Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$92K Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

6 buyers, $977K (18 lots) Β· 1 seller, $45K (4 lots)

InsiderBuysBoughtSellsSoldLast
Daniel A. Pryor1$289K 4$45KDec 9, 2025
Engert Oliver13$238K 0–Jun 15, 2026
McDonald Damien1$200K 0–Sep 11, 2025
Bradley J. Tandy1$101K 0–Aug 22, 2025
Kleckner John1$75K 0–Nov 25, 2025
Berry Phillip Benjamin (BEN)1$74K 0–Aug 20, 2025

5%+ holders

HolderStakeClassScheduleEvent
Blackrock, Inc. 16.0% 13GJul 28, 2026 filing β†—
American Century Investment Management, Inc. 10.6% 13GJul 8, 2026 filing β†—
American Century Companies, Inc. 10.6% 13GJul 8, 2026 filing β†—
Stowers Institute for Medical Research 10.6% 13GJul 8, 2026 filing β†—
Vanguard Portfolio Management 6.8% 13GApr 29, 2026 filing β†—
Vanguard Capital Management 5.2% 13GApr 29, 2026 filing β†—
Diamond Hill Capital Management Inc 5.0% 13GFeb 6, 2025 filing β†—
American Century Capital Portfolios, Inc. exited 13GJul 8, 2026 filing β†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Officer/director changes (5.02)May 19, 2026 filing β†—
Shareholder vote (5.07)May 19, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 19, 2026 filing β†—
Earnings (2.02)May 7, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 7, 2026 filing β†—
Earnings (2.02)Feb 26, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 26, 2026 filing β†—
Reg FD disclosure (7.01)Jan 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jan 12, 2026 filing β†—
Officer/director changes (5.02)Dec 10, 2025 filing β†—
Material agreement (1.01)Dec 8, 2025 filing β†—
New financial obligation (2.03)Dec 8, 2025 filing β†—
Financial Statements and Exhibits (9.01)Dec 8, 2025 filing β†—
Officer/director changes (5.02)Nov 7, 2025 filing β†—
Earnings (2.02)Nov 6, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 6, 2025 filing β†—
Earnings (2.02)Aug 7, 2025 filing β†—
Financial Statements and Exhibits (9.01)Aug 7, 2025 filing β†—